Atlas Trials

Dexmedetomidine in Different Dose Levels as Adjuvant to Bupivacaine-induced Ultrasound-guided Femoral Nerve Block.

Clinical trial NCT02089932 · COMPLETED

Trial details

NCT number
NCT02089932
Sponsor
Cairo University
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
DexmedetomidineFemoral Nerve BlockArthroscopic Knee Surgery
Start date
2014-02-01
Primary completion
2015-04-01
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.